首页> 美国卫生研究院文献>International Journal of Environmental Research and Public Health >Persistence of Immunity for Hepatitis B Virus among Heathcare Workers and Italian Medical Students 20 Years after Vaccination
【2h】

Persistence of Immunity for Hepatitis B Virus among Heathcare Workers and Italian Medical Students 20 Years after Vaccination

机译:接种疫苗20年后医护人员和意大利医科学生的乙肝病毒免疫力持续存在

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Immunization of healthcare workers (HCWs) and medical students for the hepatitis B virus (HBV) is a crucial part of the hospital infection control programs. The aim of our study was to evaluate the persistence of anti-HBV specific antibodies in HCWs vaccinated during infancy or adolescence. Methods: Medical records of 734 consecutive subjects born after 1980 (481 females, 65.5% and 253 males, 34.5%) who underwent serological testing for anti-hepatitis B surface antibodies (anti-HBs) were evaluated. Results: A non-protective titer (<10 mUI) was found in 88/734 (12.0%) subjects; 84 (47.8%) of them received a booster dose of anti-hepatitis B vaccine and the anti-HBs titer of 58 subjects was measured 1 month after administration. A protective titer (anti-HBs >10 mIU/mL) was observed in almost 90% of subjects receiving the booster dose. Conclusions: A substantial percentage of HCWs had a non-protective anti-HBs titer at the time of the first employment, especially those vaccinated at birth age. However, the response to the booster dose showed that in these subjects, an anti-HBs titer <10 mIU/mL was due to the physiological decline of antibodies over the years. Therefore, primary immunization in childhood is highly effective and provides lasting immunity against HBV infection.
机译:背景:医护人员(HCW)和医学生的乙型肝炎病毒(HBV)免疫是医院感染控制计划的重要组成部分。我们研究的目的是评估在婴儿期或青春期接种的HCW中抗HBV特异性抗体的持久性。方法:对1980年以后出生的734名连续受试者的医学记录进行了评估(女性481位,占65.5%,男性253位,占34.5%),接受了抗乙型肝炎表面抗体血清学检测。结果:在88/734(12.0%)受试者中发现了非保护性滴度(<10 mUI);他们中的84人(47.8%)接受了加强剂量的抗乙型肝炎疫苗,在给药后1个月测量了58名受试者的抗HBs效价。在接受加强剂量的几乎90%的受试者中观察到保护性滴度(抗HBs> 10 mIU / mL)。结论:大量的HCW在首次使用时具有非保护性的抗HBs滴度,尤其是在出生时接种疫苗的人。然而,对加强剂量的反应表明,在这些受试者中,抗-HBs滴度<10 mIU / mL是由于多年来抗体的生理下降所致。因此,儿童期的初次免疫非常有效,并且可以持久抵抗HBV感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号